However, we observed that critically ill patients with COVID-19 showed increased IFN responses and ZBP1 expression compared to non-critical patients with COVID-19, suggesting that IFNs and ZBP1 are associated with the disease progression and mortality. The gene discussed is ZBP1; the disease is COVID-19.